SC
Shivprakash Chinnappa Chinnappa
About Shivprakash Chinnappa Chinnappa
Data last updated:
Shivprakash Chinnappa Chinnappa is a Managing Director at Avance Phytotherapies Private Limited (since 2004), Director at Intervein Laboratories Private Limited (since 2005) and Director at Synchron Research Services Private Limited (since 1998), and holds 3 more current directorships. The companies operate in Healthcare, Transport and Logistics and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹69.7 Lakh; the largest is Avance Phytotherapies Private Limited at ₹47.3 Lakh (FY 2023). Earlier, Shivprakash Chinnappa Chinnappa was a Director at Parexel International Clinical Research Private Limited (2006–2010) and Director at Qualisync Pharma Innovations Private Limited (from 2008) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avance Phytotherapies Private Limited U73100GJ2004PTC044109 | Managing Director | 10 May 2004 | 2004 | ₹47.3 Lakh (FY 2023) | Active |
 Intervein Laboratories Private Limited U85110GJ2005PTC046803 | Director | 21 Sep 2005 | 2005 | ₹14.1 Lakh (FY 2025) | Active |
 Synchron Research Services Private Limited U85110GJ1998PTC034181 | Director | 26 May 1998 | 1998 | ₹7.4 Lakh (FY 2023) | Active |
 Novelgenix Therapeutics Private Limited U74140GJ2011PTC065969 | Managing Director | 20 Jun 2011 | 2011 | ₹93,183 (FY 2025) | Active |
 Effistry Welness & Beauty Private Limited U20232GJ2026PTC180946 | Director | 19 Jul 2026 | 2026 | Active | |
| Apiqule Pharmachem Llp AAZ-9994 | Designated Partner | 23 Dec 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Parexel International Clinical Research Private Limited U74220KA2006PTC039077 | Director | 12 Oct 2006 | 2006 | ₹21.49 Cr (FY 2025) | Active |
| Qualisync Pharma Innovations Private Limited U24230KA2008PTC046562 | Director | 26 May 2008 | 2008 | Strike Off | |
 Avance Phyto Drugs Private Limited U51507GJ2012PTC071433 | Director | 06 Aug 2012 | 2012 | Strike Off | |
| Crew Smo (India) Private Limited U73100TG2010PTC067977 | Director | 16 Apr 2010 | 2010 | Strike Off | |
| Innovance Research Private Limited U73100GJ2006PTC048113 | Managing Director | 10 Mar 2007 | 2006 | Strike Off | |
| Intervein Pharmaceutical Solutions Private Limited U73100GJ2017PTC097367 | Director | 17 May 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shivprakash Chinnappa Chinnappa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harsh Shivprakash Rathnam | 08634332 | Avance Phytotherapies Private Limited , Novelgenix Therapeutics Private Limited and 1 more | Director |
| Pundarikakshudu Kilambi | 02437252 | Avance Phytotherapies Private Limited | Director |
| Sagi Radhakrishna Rao | 02466327 | Intervein Laboratories Private Limited | Additional Director |
| Urvashi Shivprakash Rathnam | 00021251 | Synchron Research Services Private Limited | Director |
| Monika Kamalnain Verma | 02876409 | Novelgenix Therapeutics Private Limited | Director |
| Mira J Shah | 11837782 | Effistry Welness & Beauty Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivprakash Chinnappa Chinnappa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivprakash Chinnappa Chinnappa
Shivprakash Chinnappa Chinnappa currently holds 6 directorships: Avance Phytotherapies Private Limited (Managing Director, since 10 May 2004, revenue ₹47.3 Lakh (FY 2023)); Intervein Laboratories Private Limited (Director, since 21 Sep 2005, revenue ₹14.1 Lakh (FY 2025)); Synchron Research Services Private Limited (Director, since 26 May 1998, revenue ₹7.4 Lakh (FY 2023)); Novelgenix Therapeutics Private Limited (Managing Director, since 20 Jun 2011, revenue ₹93,183 (FY 2025)); Effistry Welness & Beauty Private Limited (Director, since 19 Jul 2026); and 1 more.
Shivprakash Chinnappa Chinnappa was first appointed on 26 May 1998 as Director at Synchron Research Services Private Limited. The most recent appointment on record is 19 Jul 2026 at Effistry Welness & Beauty Private Limited.
The 4 current companies of Shivprakash Chinnappa Chinnappa that report revenue have a combined latest revenue of ₹69.7 Lakh: Avance Phytotherapies Private Limited ₹47.3 Lakh (FY 2023); Intervein Laboratories Private Limited ₹14.1 Lakh (FY 2025); Synchron Research Services Private Limited ₹7.4 Lakh (FY 2023); Novelgenix Therapeutics Private Limited ₹93,183 (FY 2025).
Shivprakash Chinnappa Chinnappa held 6 earlier board appointments: Parexel International Clinical Research Private Limited (Director, 12 Oct 2006 to 23 Sep 2010); Qualisync Pharma Innovations Private Limited (Director, from 26 May 2008); Avance Phyto Drugs Private Limited (Director, from 06 Aug 2012); Crew Smo (India) Private Limited (Director, from 16 Apr 2010); Innovance Research Private Limited (Managing Director, from 10 Mar 2007); and 1 more.
The current boards of Shivprakash Chinnappa Chinnappa's companies include Harsh Shivprakash Rathnam (Avance Phytotherapies Private Limited), Pundarikakshudu Kilambi (Avance Phytotherapies Private Limited), Sagi Radhakrishna Rao (Intervein Laboratories Private Limited), Urvashi Shivprakash Rathnam (Synchron Research Services Private Limited), Monika Kamalnain Verma (Novelgenix Therapeutics Private Limited), Mira J Shah (Effistry Welness & Beauty Private Limited).